Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
21,438,572
-
Share change
-
+442,888
-
Total reported value
-
$870,084,792
-
Put/Call ratio
-
141%
-
Price per share
-
$40.58
-
Number of holders
-
143
-
Value change
-
+$18,200,719
-
Number of buys
-
60
-
Number of sells
-
69
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2019
As of 31 Dec 2019,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,438,572 shares.
The largest 10 holders included
ROYAL BANK OF CANADA, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, GOLDMAN SACHS GROUP INC, Aperio Group, LLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, and Parametric Portfolio Associates LLC.
This page lists
143
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.